Dexcom Stelo Glucose Biosensor
Payments companies reported to CMS as associated with Dexcom Stelo Glucose Biosensor. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Dexcom Stelo Glucose Biosensor, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Dexcom Stelo Glucose Biosensor
These are the largest totals companies reported as associated with Dexcom Stelo Glucose Biosensor. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Pablo Mora | Dallas, TX | Endocrinology, Diabetes & Metabolism | $61,197.28 |
| Anita Swamy | Chicago, IL | Pediatric Endocrinology | $60,722.24 |
| Aaron King | San Antonio, TX | Family Medicine | $44,862.41 |
| Nicholas Argento | Laurel, MD | Endocrinology, Diabetes & Metabolism | $44,380.15 |
| Thomas Martens | Brooklyn Center, MN | Internal Medicine | $41,727.23 |
| Martin Sarkar | Frederick, MD | Endocrinology, Diabetes & Metabolism | $38,206.01 |
| Gregg Gerety | Albany, NY | Endocrinology, Diabetes & Metabolism | $30,871.76 |
| Arelis Madera | Port Charlotte, FL | Endocrinology, Diabetes & Metabolism | $28,765.73 |
| Catherine Kilpatrick | Fayetteville, AR | Endocrinology, Diabetes & Metabolism | $27,167.19 |
| Davida Kruger | Detroit, MI | Nurse Practitioner | $25,091.65 |
Prescribed Dexcom Stelo Glucose Biosensor?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.